Patient preferences for treating refractory overactive bladder in the UK

International Urology and Nephrology
Hashim HashimLinda Cardozo

Abstract

To evaluate patient preferences for refractory overactive bladder (OAB) treatments: sacral neuromodulation (SNM), onabotulinum toxin A (Botox(®)), and percutaneous tibial nerve stimulation (PTNS). A cross-sectional Web survey was conducted with UK idiopathic OAB patients, recruited by a market research company. Preference was explored using direct questioning, comparing SNM, Botox, and PTNS, and via best-worst scaling (BWS). In BWS, patients prioritized subsets of 13 treatment characteristics (attributes) across 13 choice tasks, identifying the attribute they considered best and worst in each task. The attributes were those that were identified by patients in previous qualitative interviews as influential in treatment selection. BWS scores for each attribute, ranging from 1.0 (most favourable) to -1.0 (most unfavourable), were calculated based on the rates they were identified as best and as worst. To identify attributes that may influence treatment choice, BWS scores were compared among patients based on their most preferred treatment using analyses of variance; pairwise differences were assessed using Tukey's multiple comparisons test. The study population (N = 139) was 77 % female, had a mean age of 49 years, and were diagno...Continue Reading

References

Apr 16, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A S Arunkalaivanan, J W Barrington
May 21, 2010·Health and Quality of Life Outcomes·Kathleen M BeusterienSteve Bramham-Jones
Jun 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Terry N Flynn
Dec 21, 2010·The Journal of Urology·Randall K LeongStefan G De Wachter
Oct 15, 2011·The Patient·John F P BridgesAxel Mühlbacher
Jan 26, 2012·International Urogynecology Journal·Linda BrubakerKarl-Dietrich Sievert
Jul 28, 2013·Expert Opinion on Pharmacotherapy·Dean S EltermanJack Barkin

❮ Previous
Next ❯

Citations

Jan 9, 2016·Health Economics Review·Axel C MühlbacherF Reed Johnson
Dec 1, 2018·Neurourology and Urodynamics·Le Mai TuKarel Everaert
Feb 27, 2016·F1000Research·Karen M Wallace, Marcus J Drake
Nov 28, 2016·International Urogynecology Journal·Pawel MiotlaTomasz Rechberger
Jul 13, 2016·PharmacoEconomics·Kei Long CheungMickael Hiligsmann
Oct 13, 2018·Der Urologe. Ausg. A·Arndt van Ophoven
Apr 4, 2019·Archives of Gynecology and Obstetrics·Matthias OelkeChristl Reisenauer
Nov 22, 2020·International Journal of Clinical Practice·Arun SahaiDudley Robinson
Nov 23, 2020·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X Gamé, V Phé
Jul 2, 2021·Clinical Therapeutics·Tara A LavelleJohn F P Bridges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Beckwith-Wiedemann syndrome

Beckwith-Wiedemann syndrome is an imprinting disorder characterized by overgrowth, congenital malformations and predisposition to tumors. Discover the latest research on Beckwith-Wiedemann Syndrome here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.